Zdrowie i gospodarka · 10/10/2019

FDA Hosts Public Workshop on Pediatric Clinical Trial Endpoints for Rare Diseases

The FDA Office of Pediatric Therapeutics is hosting a public workshop to discuss pediatric patient perspectives in the development of clinical trial endpoints for rare diseases, as part of its Advancing the Development of Pediatric Therapeutics (ADEPT 6) initiative.